BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Moria S.A. Acquires The Line Of Single Use Instruments From Fulcrum (Medical Devices) Ltd.


10/19/2005 5:09:03 PM

ANTONY, France & DOYLESTOWN, Pa. & TOKYO--(BUSINESS WIRE)--July 29, 2005--MORIA announced today the acquisition of the full line of single use instruments from FULCRUM (MEDICAL DEVICES) Ltd., which are currently sold under the umbrella trademark "ONE". The acquisition concerns all fixed assets, patents, trademarks, and inventories related to the ONE product line. The ONE product range includes forceps, scissors, manipulators, and specula for ophthalmic surgery and feature a unique, innovative, ergonomic design, including plastic handles and titanium tips of the finest quality. Disposable instruments are gaining in popularity, and correspond to a strong market demand for increased safety and better patient turnaround. Requiring lower capital investment and eliminating the need for cleaning, autoclaving, and repairs, single use instruments are a more attractive financial model than reusable products.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES